Quick Asked: Second Genome Contact Us?
Last update: 29 Mar, 2024 
280 Views
Who is second genome? Founded in 2009 by leading experts in microbial research, molecular diagnostics, and biotechnology R&D, Second Genome is using its proprietary Microbiome Signature Discovery platform to generate novel insights relating the microbiome with a wide range of human health disorders.What are second genomes precision therapeutics? Second Genome’s two Precision Therapeutics programs include Immuno-oncology, to turn immune checkpoint inhibitor non-responders to responders, and Gastrointestinal Disorders, to directly improve mucosal healing in gastrointestinal disorders. Also progressing a Biomarker program, Second Genome aims to improve cancer diagnosis and therapy selection.How much money has 2nd genome raised in funding? Second Genome has raised a total of $87.9M in funding over 5 rounds. Their latest funding was raised on Mar 15, 2019 from a Series B round.How to contact novogene ait genomics singapore? NovogeneAIT Genomics Singapore Pte. Please leave us a message at: [email protected] with any suggestion on your experience with Novogene.
Listing Results Second Genome Contact Us? Question Answers
Second Genome, Inc. Information Second Genome, Inc. Profile
Second Genome’s culture of excellence also makes us the expert-partner of choice for exciting microbiome research projects with leading corporations, academic institutions and government. While we are driven by science, it is our people who are at the core of our success.
Second Genome Careers
(650) 440-4606 Founded in 2009 by leading experts in microbial research and drug discovery, Second Genome is pioneering microbiome science to generate novel therapeutics in a range of diseases, such as inflammatory bowel disease and metabolic disease. Contact Us. 1000 Marina Blvd, Suite #500 Brisbane, CA 94005 [email protected] (650) 440-4606.
Second Genome Home
Second Genome Presents Preclinical Data at SITC 2021 Demonstrating that a CXCR3-Positive Allosteric Modulator, SG-3-00802, Targets a Key Mechanism Required for Efficacious Immunotherapy. Contact Us. 1000 Marina Blvd, Suite #500 Brisbane, CA 94005 [email protected]